# Biotech on The No Agenda Show

Biotech comes up in 10 chapters across 10 episodes of The No Agenda Show, from February 2013 to May 2026.

- **Chapters:** 10
- **Episodes:** 10
- **Discussed:** February 2013 – May 2026
- **Related topics:** [Astrazeneca](https://search.noagendashow.net/topic/astrazeneca.md), [India](https://search.noagendashow.net/topic/india.md), [2024 Election](https://search.noagendashow.net/topic/2024-election.md), [2030](https://search.noagendashow.net/topic/2030.md), [Aging](https://search.noagendashow.net/topic/aging.md), [Big Pharma](https://search.noagendashow.net/topic/big-pharma.md), [Bloomberg](https://search.noagendashow.net/topic/bloomberg.md), [Cancer Treatment](https://search.noagendashow.net/topic/cancer-treatment.md), [Cattle](https://search.noagendashow.net/topic/cattle.md), [Deborah Birx](https://search.noagendashow.net/topic/deborah-birx.md)

## Chapters 1–10 of 10

### Big Pharma Influence and the FDA Shakeup

- **Episode:** [1868: Lubio](https://search.noagendashow.net/episode/1868-lubio.md)
- **Published:** 2026-05-14
- **Time:** 1:49:16–1:51:36
- **Transcript:** https://search.noagendashow.net/episode/1868-lubio/chapter/big-pharma-influence-and-the-fda-shakeup.md

Analysts suggest that Marty McCary's tenure was marked by significant turnover and mass layoffs of veteran agency staff. A Bloomberg analyst noted that McCary was "very good" to those on the "buy side," implying a cozy relationship with pharmaceutical investors. The hosts question why Robert F. Kennedy Jr. has not been more vocal about the resignation.

Keywords: [big pharma](https://search.noagendashow.net/topic/big-pharma.md), [bloomberg](https://search.noagendashow.net/topic/bloomberg.md), [marty mccary](https://search.noagendashow.net/topic/marty-mccary.md), [biotech](https://search.noagendashow.net/topic/biotech.md), [layoffs](https://search.noagendashow.net/topic/layoffs.md), [rfk jr](https://search.noagendashow.net/topic/rfk-jr.md)

### Deborah Birx, Armata Pharmaceuticals and Mass Cattle Testing

- **Episode:** [1666: Wyrd](https://search.noagendashow.net/episode/1666-wyrd.md)
- **Published:** 2024-06-06
- **Time:** 46:16–51:10
- **Transcript:** https://search.noagendashow.net/episode/1666-wyrd/chapter/deborah-birx-armata-pharmaceuticals-and-mass-cattle-testing.md

Dr. Deborah Birx, now representing Armata Pharmaceuticals, called for weekly PCR testing of every dairy cow in the United States to track asymptomatic bird flu spread. The hosts calculate the immense cost of such a program—potentially billions of dollars per week—and suggest it is a strategy to benefit biotech firms and testing manufacturers.

Keywords: [deborah birx](https://search.noagendashow.net/topic/deborah-birx.md), armata pharmaceuticals, [cattle](https://search.noagendashow.net/topic/cattle.md), [pcr testing](https://search.noagendashow.net/topic/pcr-testing.md), [biotech](https://search.noagendashow.net/topic/biotech.md)

### India Vaccination Drive, Bharat Biotech and AstraZeneca

- **Episode:** [1309: Vaxsaline](https://search.noagendashow.net/episode/1309-vaxsaline.md)
- **Published:** 2024-03-07
- **Time:** 1:01:05–1:05:24
- **Transcript:** https://search.noagendashow.net/episode/1309-vaxsaline/chapter/india-vaccination-drive-bharat-biotech-and-astrazeneca.md

India is preparing for a massive vaccination drive using the AstraZeneca jab and a local version from Bharat Biotech. Despite having four times the U.S. population and significant squalor, India reports half the number of COVID-19 deaths. The country recently conducted nationwide "dry runs" to test health infrastructure, cold storage, and online databases for mass inoculation.

Keywords: [india](https://search.noagendashow.net/topic/india.md), ganges, [astrazeneca](https://search.noagendashow.net/topic/astrazeneca.md), bharat biotech, dry run, health infrastructure

### Vivek Ramaswamy as a Trump Surrogate

- **Episode:** [1616: Buying Quiet](https://search.noagendashow.net/episode/1616-buying-quiet.md)
- **Published:** 2023-12-17
- **Time:** 1:13:11–1:17:23
- **Transcript:** https://search.noagendashow.net/episode/1616-buying-quiet/chapter/vivek-ramaswamy-as-a-trump-surrogate.md

Vivek Ramaswamy's performance in town halls is analyzed as a strategic "stick" or foil for Donald Trump. Ramaswamy has shifted from a biotech CEO to a vocal political figure, often delivering Trump's core messages with a more polished and aggressive rhetorical style.

Keywords: [vivek ramaswamy](https://search.noagendashow.net/topic/vivek-ramaswamy.md), [donald trump](https://search.noagendashow.net/topic/donald-trump.md), [2024 election](https://search.noagendashow.net/topic/2024-election.md), [biotech](https://search.noagendashow.net/topic/biotech.md), [political strategy](https://search.noagendashow.net/topic/political-strategy.md)

### Show Sign-off, End of Show Mix and Media Montage

- **Episode:** [1527: Grip & Grin](https://search.noagendashow.net/episode/1527-grip-grin.md)
- **Published:** 2023-02-05
- **Time:** 2:44:30–2:50:03
- **Transcript:** https://search.noagendashow.net/episode/1527-grip-grin/chapter/show-sign-off-end-of-show-mix-and-media-montage.md

The hosts sign off from FEMA Region 6 and Silicon Valley, directing listeners to the No Agenda stream for "Hog Story." The episode concludes with a complex media montage and music mix featuring clips about Chinese balloons, biotech, fentanyl seizures, and the "Agenda 2030" initiative. Credits are given to the mix producers and the "value for value" supporters.

Keywords: leo lapuke, [matty j](https://search.noagendashow.net/topic/matty-j.md), [biotech](https://search.noagendashow.net/topic/biotech.md), [fentanyl](https://search.noagendashow.net/topic/fentanyl.md), [2030](https://search.noagendashow.net/topic/2030.md), [end of show mix](https://search.noagendashow.net/topic/end-of-show-mix.md)

### India Vaccine Drive, Covaxin Controversy

- **Episode:** [1313: Q Victims](https://search.noagendashow.net/episode/1313-q-victims.md)
- **Published:** 2021-01-17
- **Time:** 3:19:13–3:22:45
- **Transcript:** https://search.noagendashow.net/episode/1313-q-victims/chapter/india-vaccine-drive-covaxin-controversy.md

India begins a nationwide vaccine drive using the Oxford-AstraZeneca shot and the indigenous "Covaxin" by Bharat Biotech. The latter has raised alarm bells for being approved before clinical trials were concluded. The hosts question why India's death numbers are so low compared to the U.S. despite its much larger population.

Keywords: [india](https://search.noagendashow.net/topic/india.md), [narendra modi](https://search.noagendashow.net/topic/narendra-modi.md), bharat biotech, covaxin, [astrazeneca](https://search.noagendashow.net/topic/astrazeneca.md)

### PetriBio Biotech Startup, Sir Olympus

- **Episode:** [1299: King Mitch](https://search.noagendashow.net/episode/1299-king-mitch.md)
- **Published:** 2020-12-01
- **Time:** 2:07:41–2:09:56
- **Transcript:** https://search.noagendashow.net/episode/1299-king-mitch/chapter/petribio-biotech-startup-sir-olympus.md

Joe S. Chinaman, newly knighted as Sir Olympus, announced the launch of his biotech startup, PetriBio. The company focuses on developing treatments for aging-related diseases by utilizing peptides and biomolecules from the gut microbiome. He requested "PCR primers and master mix" for the No Agenda roundtable.

Keywords: petribio, [biotech](https://search.noagendashow.net/topic/biotech.md), [microbiome](https://search.noagendashow.net/topic/microbiome.md), [peptides](https://search.noagendashow.net/topic/peptides.md), [aging](https://search.noagendashow.net/topic/aging.md)

### Donor Recognition, Eagle Scouts and Biotech Jobs

- **Episode:** [1035: Hundos](https://search.noagendashow.net/episode/1035-hundos.md)
- **Published:** 2018-05-21
- **Time:** 2:03:56–2:12:05
- **Transcript:** https://search.noagendashow.net/episode/1035-hundos/chapter/donor-recognition-eagle-scouts-and-biotech-jobs.md

A second round of donor thank-yous includes several Eagle Scouts and a mention of "Knobcon," a synthesizer convention in Illinois. The hosts reiterate that the show's lack of corporate advertising allows for honest reporting on the pharmaceutical industry. A "matchmaking" effort is also mentioned to help a biotech professional find employment through the listener network.

Keywords: [eagle scouts](https://search.noagendashow.net/topic/eagle-scouts.md), knobcon, [murfreesboro](https://search.noagendashow.net/topic/murfreesboro.md), [biotech](https://search.noagendashow.net/topic/biotech.md), [value for value](https://search.noagendashow.net/topic/value-for-value.md), [donations](https://search.noagendashow.net/topic/donations.md)

### FDA Biosimilar Approval, Biotech Drug Pricing

- **Episode:** [702: Toddler Wage Gap](https://search.noagendashow.net/episode/702-toddler-wage-gap.md)
- **Published:** 2015-03-08
- **Time:** 1:16:21–1:20:01
- **Transcript:** https://search.noagendashow.net/episode/702-toddler-wage-gap/chapter/fda-biosimilar-approval-biotech-drug-pricing.md

The FDA has approved the first "biosimilar" drug, a low-cost version of the biotech drug Neupogen used for cancer patients. Unlike traditional generics, biosimilars are derived from living organisms; the discussion notes that the lack of transparent pricing for these drugs allows biotech firms to maintain high costs, exemplified by a recent $21 billion company buyout.

Keywords: [fda](https://search.noagendashow.net/topic/fda.md), biosimilar, [biotech](https://search.noagendashow.net/topic/biotech.md), [cancer treatment](https://search.noagendashow.net/topic/cancer-treatment.md), [drug pricing](https://search.noagendashow.net/topic/drug-pricing.md)

### Islam Siddiqui, CropLife America and Monsanto

- **Episode:** [491: Pope and Change](https://search.noagendashow.net/episode/491-pope-and-change.md)
- **Published:** 2013-02-28
- **Time:** 57:22–59:15
- **Transcript:** https://search.noagendashow.net/episode/491-pope-and-change/chapter/islam-siddiqui-croplife-america-and-monsanto.md

Dr. Islam Siddiqui, a former lobbyist for CropLife America, is highlighted as the chief agricultural negotiator for the U.S. government. The hosts point out the conflict of interest in having a representative of the pesticide and biotech industries, including Monsanto, negotiating agricultural policy.

Keywords: islam siddiqui, croplife america, [monsanto](https://search.noagendashow.net/topic/monsanto.md), [pesticides](https://search.noagendashow.net/topic/pesticides.md), [biotech](https://search.noagendashow.net/topic/biotech.md)

---

This is the markdown version of a page on The No Agenda Show for AI agents. Every public page on this site has one: add `.md` to its URL, or request it with `Accept: text/markdown`.

- [Site index for agents (llms.txt)](https://search.noagendashow.net/llms.txt)
- [Home](https://search.noagendashow.net/index.md)
- [Search transcripts](https://search.noagendashow.net/search.md)
- [All episodes](https://search.noagendashow.net/episodes.md)
- [Topics](https://search.noagendashow.net/topics.md)
- [People](https://search.noagendashow.net/people.md)
